However, there is an increase in the frequency of CD4+CD39+ and CD8+CD39+ T cells with greater expression of CD39 in patients with severe COVID-19 (Figures 2A, B), indicating the prevalence of activated T cells or even regulatory T cells in infected subjects. This evidence concerns the gene ENTPD1 and COVID-19.